Association of resection type, nodal evaluation, and survival in early-stage lung squamous cell carcinoma
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: While recent trials suggest sublobar resection is non-inferior to lobectomy for stage IA non-small cell lung cancer (NSCLC), patients with squamous cell carcinoma (SCC) were underrepresented. We aimed to evaluate outcomes of sublobar resection versus lobectomy in early-stage SCC. Methods: Using the National Cancer Database (NCDB; 2010–2022), we identified patients >18 years with stage IA SCC. We compared demographics, tumor characteristics, perioperative outcomes, nodal evaluation, and survival between patients undergoing lobectomy or sublobar resection. Overall survival was evaluated using Kaplan-Meier analysis and Cox proportional hazards regression, with sequential adjustment for lymph node evaluation to assess its influence on survival estimates. Results: Among 207 patients, 63% underwent lobectomy and 37% sublobar resection. The sublobar group was older (72.0 vs. 69.2 years, P=0.006); other factors were similar. Fewer lymph nodes were examined in sublobar cases (1 vs. 9, P<0.001). Although not statistically significant, survival trended lower with sublobar resection (hazard ratio 1.57, 95% confidence interval: 0.91–2.72, P=0.10; median survival 4.1 vs. 8.6 years). Conclusions: Although overall survival appeared higher following lobectomy, this association was attenuated after adjustment for lymph node evaluation and was no longer statistically significant. These findings highlight the importance of adequate nodal assessment and should be considered hypothesis-generating.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Association of resection type, nodal evaluation, and survival in early-stage lung squamous cell carcinoma
- Date Crossref
- 01/08/2026
- Éditeur
- AME Publishing Company
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Arizona Department of General Surgery pays non établi dans la noticeUniversité ou école supérieure
Department of General Surgery — University of Arizona.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.